Activating mAbs increased the frequency of apoptosis in CTCs and tumor cells in metastatic nodules, through upmodulation of Bax mRNA expression, and downmodulation of Bcl-xL mRNA expression (119). This evidence concerns the gene BCL2L1 and neoplasm.